Crossref
Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review
Journal of Advanced Pharmacy Education and Research · 2026 · 16 (1) · 201-210
DOI: 10.51847/bfye5lnqza ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Pharmacy Education and Research, 2026. Verfasst von Yosra Alhindi. Die Arbeit nennt 109 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alhindi, Y. (2026). Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review. Journal of Advanced Pharmacy Education and Research, 16(1), 201-210. https://doi.org/10.51847/bfye5lnqza
Vancouver
Alhindi Y. Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review. Journal of Advanced Pharmacy Education and Research. 2026;16(1):201-210. doi:10.51847/bfye5lnqza
BibTeX
@article{Alhindi2026,
author = {Alhindi, Yosra},
title = {Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review},
journal = {Journal of Advanced Pharmacy Education and Research},
year = {2026},
volume = {16},
number = {1},
pages = {201--210},
doi = {10.51847/bfye5lnqza}
}
EUVIMED